Related Experiment Video
Updated: May 8, 2026
11:07
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Transdermal delivery: product and patent update
1Department of Pharmacal Sciences, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA. Dr.hgupta@yahoo.com.
Recent Patents on Drug Delivery & Formulation
|September 13, 2013
Summary
Transdermal drug delivery offers a viable alternative for medications, especially those affected by first-pass metabolism. This review details 16 drugs and 22 products, alongside clinical trials and recent patents in transdermal systems.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Biotechnology
Background:
- Transdermal drug delivery bypasses oral and parenteral routes, ideal for drugs undergoing first-pass metabolism.
- It enables controlled dosing and sustained therapeutic blood levels.
- This method presents an attractive alternative for various pharmaceutical applications.
Purpose of the Study:
- To provide an updated review of transdermal drug delivery systems.
- To compile information on marketed transdermal products, clinical trials, and recent patents.
- To serve as a comprehensive resource for transdermal drug delivery research.
Main Methods:
- Literature review of transdermal drug delivery systems.
- Compilation of 16 drugs and 22 marketed products.
- Summary of recent patents (last 5 years) and ongoing clinical trials.
Main Results:
- Detailed information on 16 specific drugs and 22 transdermal products is presented.
- An overview of current clinical trials in transdermal systems is provided.
- Key patents granted in the last five years across various pharmacological categories are summarized.
Conclusions:
- Transdermal drug delivery is a significant area of pharmaceutical research and development.
- The review consolidates essential information on products, trials, and patents, aiding researchers.
- This work highlights the growing importance and innovation in transdermal therapeutics.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...